CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, cilt.9, ss.1207-1216, 2014 (SCI İndekslerine Giren Dergi)
Background and objectives Cardiovascular disease is the leading cause of death in patients with CKD. IL-10 is considered an antiatherosclerotic cytokine. However, previous studies have failed to observe an association between IL40 and cardiovascular disease in CKD. This study aimed to evaluate whether serum IL-10 levels were associated with the risk of cardiovascular events in CKD patients.